These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 30338356)

  • 1. Bacteriocins: perspective for the development of novel anticancer drugs.
    Baindara P; Korpole S; Grover V
    Appl Microbiol Biotechnol; 2018 Dec; 102(24):10393-10408. PubMed ID: 30338356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Classification and mode of action of membrane-active bacteriocins produced by gram-positive bacteria.
    Oscáriz JC; Pisabarro AG
    Int Microbiol; 2001 Mar; 4(1):13-9. PubMed ID: 11770815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanistic action of pediocin and nisin: recent progress and unresolved questions.
    Montville TJ; Chen Y
    Appl Microbiol Biotechnol; 1998 Nov; 50(5):511-9. PubMed ID: 9917136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioengineering of the model lantibiotic nisin.
    Field D; Cotter PD; Ross RP; Hill C
    Bioengineered; 2015; 6(4):187-92. PubMed ID: 25970137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of Azurin-Like Anticancer Bacteriocins from Human Gut Microbiome through Homology Modeling and Molecular Docking against the Tumor Suppressor p53.
    Nguyen C; Nguyen VD
    Biomed Res Int; 2016; 2016():8490482. PubMed ID: 27239476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The case for class II bacteriocins: A biophysical approach using "suicide probes" in receptor-free hosts to study their mechanism of action.
    Ríos Colombo NS; Chalón MC; Dupuy FG; Gonzalez CF; Bellomio A
    Biochimie; 2019 Oct; 165():183-195. PubMed ID: 31381962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibacterial peptides "bacteriocins": an overview of their diverse characteristics and applications.
    Nishie M; Nagao J; Sonomoto K
    Biocontrol Sci; 2012 Mar; 17(1):1-16. PubMed ID: 22451427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimicrobial Peptide Production and Purification.
    Suda S; Field D; Barron N
    Methods Mol Biol; 2017; 1485():401-410. PubMed ID: 27730566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation of the cytotoxicity of eukaryotic and prokaryotic antimicrobial peptides in intestinal epithelial cells in vitro.
    Maher S; McClean S
    Biochem Pharmacol; 2006 Apr; 71(9):1289-98. PubMed ID: 16530733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biomedical applications of nisin.
    Shin JM; Gwak JW; Kamarajan P; Fenno JC; Rickard AH; Kapila YL
    J Appl Microbiol; 2016 Jun; 120(6):1449-65. PubMed ID: 26678028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. On bacteriocin delivery systems and potential applications.
    Arthur TD; Cavera VL; Chikindas ML
    Future Microbiol; 2014; 9(2):235-48. PubMed ID: 24571075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overview of ribosomal and non-ribosomal antimicrobial peptides produced by Gram positive bacteria.
    Tajbakhsh M; Karimi A; Fallah F; Akhavan MM
    Cell Mol Biol (Noisy-le-grand); 2017 Oct; 63(10):20-32. PubMed ID: 29096754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimicrobial peptides with selective antitumor mechanisms: prospect for anticancer applications.
    Deslouches B; Di YP
    Oncotarget; 2017 Jul; 8(28):46635-46651. PubMed ID: 28422728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bacteriocins in Cancer Treatment: Mechanisms and Clinical Potentials.
    Wang Y; Wang Y; Sun T; Xu J
    Biomolecules; 2024 Jul; 14(7):. PubMed ID: 39062544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lantibiotics, class I bacteriocins from the genus Bacillus.
    Lee H; Kim HY
    J Microbiol Biotechnol; 2011 Mar; 21(3):229-35. PubMed ID: 21464591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bacteriocins as Potential Anticancer Agents.
    Kaur S; Kaur S
    Front Pharmacol; 2015; 6():272. PubMed ID: 26617524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pediocin PA-1, a wide-spectrum bacteriocin from lactic acid bacteria.
    Rodríguez JM; Martínez MI; Kok J
    Crit Rev Food Sci Nutr; 2002 Mar; 42(2):91-121. PubMed ID: 11934133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ribosomally synthesized peptides with antimicrobial properties: biosynthesis, structure, function, and applications.
    Papagianni M
    Biotechnol Adv; 2003 Sep; 21(6):465-99. PubMed ID: 14499150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lactococcal membrane-permeabilizing antimicrobial peptides.
    Zendo T; Yoneyama F; Sonomoto K
    Appl Microbiol Biotechnol; 2010 Sep; 88(1):1-9. PubMed ID: 20645082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibacterial activity of class I and IIa bacteriocins combined with polymyxin E against resistant variants of Listeria monocytogenes and Escherichia coli.
    Naghmouchi K; Belguesmia Y; Baah J; Teather R; Drider D
    Res Microbiol; 2011; 162(2):99-107. PubMed ID: 20868743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.